title: Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.
abstract: Beta-lactam-resistant Enterobacteriaceae represent an important public health problem; however, questions exist about their prevalence and the impact of recent breakpoint changes on clinical practice. We surveyed infectious disease physicians to better understand these issues. Many reported encountering resistant Enterobacteriaceae; respondents generally favored a more conservative interpretation of antimicrobial susceptibility results.
authors: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. AKallen@cdc.gov
authors: Alexander J
authors: AJ
authors: Kallen
authors: Susan E
authors: SE
authors: Beekmann
authors: Brandi
authors: B
authors: Limbago
authors: Arnold L
authors: AL
authors: Lentnek
authors: Philip M
authors: PM
authors: Polgreen
authors: Jean
authors: J
authors: Patel
authors: Arjun
authors: A
authors: Srinivasan
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000453:epidemiology*; D006306:Health Surveys; D006801:Humans; D008826:Microbial Sensitivity Tests; D010820:Physicians; D015995:Prevalence; D011634:Public Health; D047090:beta-Lactams / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams